Feminizing hormone therapy

Feminizing hormone therapy, also known as transfeminine hormone therapy, is hormone therapy and sex reassignment therapy to change the secondary sex characteristics of transgender people from masculine or androgynous to feminine. It is a common type of transgender hormone therapy (another being masculinizing hormone therapy) and is used to treat transgender women and non-binary transfeminine individuals. Some, in particular intersex people but also some non-transgender people, take this form of therapy according to their personal needs and preferences. The purpose of the therapy is to cause the development of the secondary sex characteristics of the desired sex, such as breasts and a feminine pattern of hair, fat, and muscle distribution. It cannot undo many of the changes produced by naturally occurring puberty, which may necessitate surgery and other treatments to reverse (see below). The medications used for feminizing hormone therapy include estrogens, antiandrogens, progestogens, and gonadotropin-releasing hormone modulators (GnRH modulators). Feminizing hormone therapy has been shown to likely reduce the distress and discomfort associated with gender dysphoria. Transgender hormone therapy#Requirements and Transgender hormone therapy#Accessibility Many physicians operate by the World Professional Association of Transgender Health (WPATH) Standards of Care (SoC) model and require psychotherapy and a letter of recommendation from a psychotherapist in order for a transgender person to obtain hormone therapy. Other physicians operate by an informed consent model and have no requirements for transgender hormone therapy aside from consent. Medications used in transgender hormone therapy are also sold without a prescription on the Internet by unregulated online pharmacies, and some transgender women purchase these medications and treat themselves using a do-it-yourself (DIY) or self-medication approach.

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Concepts associés (98)

Séances de cours associées (18)

Feminizing hormone therapy

Hair removal

Hair removal, also known as epilation or depilation, is the deliberate removal of body hair or head hair. Hair typically grows all over the human body and can vary in thickness and length across human populations. Hair becomes more visible during and after puberty and men tend to have thicker, more visible body hair than women. Both males and females have visible body hair on the head, eyebrows, eyelashes, armpits, genital area, arms, and legs.

Dutastéride

Le dutastéride, vendu entre autres sous le nom de marque Avodart. Est un médicament principalement utilisé pour traiter les symptômes d'une hypertrophie de la prostate . Quelques mois peuvent être nécessaires avant que les bénéfices ne se manifestent. Il est également utilisé pour la perte de cheveux du cuir chevelu chez les hommes et dans le cadre de l'hormonothérapie chez les femmes transgenres . Il est pris par voie orale.

Comprendre la dysphorie de genre BIO-450: Molecular endocrinology

Couvre le concept de dysphorie de genre, les traitements médicaux pour les personnes transgenres et leurs effets émotionnels.

Transition de genre: évaluation psychiatrique et hormonothérapie BIO-450: Molecular endocrinology

Explore la transition entre les sexes, l'évaluation psychiatrique, l'hormonothérapie, les risques et les disparités dans les soins de santé transgenres dans le monde entier.

Thérapeutique des protéines: Cibles et applications BIO-478: Pharmacology and pharmacokinetics

Explore l'utilisation de la thérapeutique des protéines en médecine, en se concentrant sur les enzymes, les protéines régulatrices et les anticorps monoclonaux.